Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework.

ABSTRACT:

Background

Previous studies have shown that patients with chronic kidney disease who are followed by a renal clinical pharmacist have improved clinical outcomes. In 2016, a consensus list of quality indicator drug therapy problems (QI-DTPs) was developed by renal clinical pharmacists to help prioritize which renal patients should receive interventions. Before QI-DTP interventions can be implemented in clinical practice, barriers to and enablers of their use need to be identified, to allow development of strategies to overcome the barriers and apply the enablers.

Objective

To identify modifiable barriers to and enablers of implementation of renal QI-DTP interventions by renal clinical pharmacists.

Methods

In this exploratory qualitative descriptive study, one-on-one, s

SUBMITTER: Nevers W 

PROVIDER: S-EPMC7308154 | biostudies-literature | 2020 May-Jun

REPOSITORIES: biostudies-literature